The dependency of DAM activation on TREM2 has also been confirmed by a recent scRNA-seq study as Trem2 deletion greatly attenuate the degree of DAM activation in the TauPS2APP AD mouse model with both Aβ and tau pathologies (Lee et al., 2021; Table 1). Here, MAPT is linked to Alzheimer disease.